Delisting risk
Propanc Biopharma (PPCB)
Preclinical developer of proenzyme therapies for solid tumors.
$1.01
Pre-market−0.01 (−1.46%)
At close$1.03(−9.29%)
Something off on this page? Send us feedback.
EPSReportedEstimate
Sep '24Nov '24Feb '25May '25Sep '25Nov '25Feb '26May '26
Reported−$95.95−$287.82−$32.23−$12.50−$0.35−$0.39−$0.30−$7.00
Estimate————————
Surprise————————
RevenueReportedEstimate
Sep '24Nov '24Feb '25May '25Sep '25Nov '25Feb '26May '26
Reported————————
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| May 2026 | — | −$7.00 | — |
| Feb 2026 | — | −$0.30 | — |
| Nov 2025 | — | −$0.39 | — |
| Sep 2025 | — | −$0.35 | — |
The latest year is open to everyone — the 39 quarters behind it read with an account. Sign in | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Sep 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Sep 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Sep 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Sep 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Oct 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Oct 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Sep 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Sep 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Sep 2016 | |||
| May 2016 | — | — | — |
| Feb 2016 | — | — | — |
| Nov 2015 | — | — | — |
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | — | −$7.00 | — | — | — | — | −7.1% |
| Feb 17, 2026 | — | −$0.30 | — | — | — | — | −4.6% |
| Nov 14, 2025 | — | −$0.39 | — | — | — | — | −2.7% |
| Sep 29, 2025 | — | −$0.35 | — | — | — | — | −7.1% |
The latest year is open to everyone — the 39 quarters behind it read with an account. Sign in | |||||||
| May 15, 2025 | |||||||
| Feb 14, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Sep 30, 2024 | |||||||
| May 15, 2024 | |||||||
| Feb 20, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Sep 28, 2023 | |||||||
| May 15, 2023 | |||||||
| Feb 9, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Sep 28, 2022 | |||||||
| May 16, 2022 | |||||||
| Feb 14, 2022 | |||||||
| Nov 12, 2021 | |||||||
| Sep 28, 2021 | |||||||
| May 14, 2021 | |||||||
| Feb 12, 2021 | |||||||
| Nov 16, 2020 | |||||||
| Oct 1, 2020 | |||||||
| May 15, 2020 | |||||||
| Feb 14, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Oct 15, 2019 | |||||||
| May 15, 2019 | |||||||
| Feb 14, 2019 | |||||||
| Nov 9, 2018 | |||||||
| Sep 17, 2018 | |||||||
| May 10, 2018 | |||||||
| Feb 9, 2018 | |||||||
| Nov 9, 2017 | |||||||
| Sep 28, 2017 | |||||||
| May 8, 2017 | |||||||
| Feb 14, 2017 | |||||||
| Nov 10, 2016 | |||||||
| Sep 28, 2016 | |||||||
| May 16, 2016 | — | — | — | — | — | — | — |
| Feb 16, 2016 | — | — | — | — | — | — | — |
| Nov 17, 2015 | — | — | — | — | — | — | — |